WithdrawnNot Applicable

Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer

Stopped: Lack of funding

Plain-language summary

This clinical trial studies colposcopy and high resolution anoscopy in screening for anal dysplasia in patients with cervical, vaginal, or vulvar dysplasia or cancer. Screening may help doctors find cancer cells early and plan better treatment for cancer

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Histological confirmation of cervical, vaginal or vulvar intraepithelial neoplasia or cancer are included * Individuals treated with prior radiation therapy and/or chemotherapy are allowed * Women with high-grade dysplasia (carcinoma in situ) are eligible, regardless of their dysplasia free interval * HIV-positive (Human Immunodeficiency Virus) and HIV-negative women will be enrolled; HIV testing will not be performed as part of the study Exclusion Criteria: * Women who are not able to consent are excluded

What they're measuring

Risk of anal dysplasia in women with cervical or vulvar dysplasia

Timeframe: Over 2 years

HPV (Human Papillomavirus) status

Timeframe: Over 2 years

Trial details

NCT IDNCT01313104

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Cervical Intraepithelial Neoplasia Grade 1 trials